Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07022470 · ClinicalTrials.gov registry record · Phase 2
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
A Phase 2 study of Cervical Cancers, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT07022470 is a Phase 2 study of Cervical Cancers that is actively recruiting participants, run by Stanford University. The registered enrollment target is 41 participants, below the 356-participant average among 3 other Cervical Cancers trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07022470, a Phase 2 study of Cervical Cancers, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Conditions Studied
Interventions
- RADIATION 3-Fraction HDR Brachytherapy
- RADIATION 4-Fraction HDR Brachytherapy
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-06-03 |
| Est. Completion | 2028-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07022470
The ClinicalTrials.gov registry entry for NCT07022470 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 356-participant average among 3 other Cervical Cancers trials with a reported enrollment target (88% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancers appearing as the primary indexed condition, and to 2 interventions - of which 3-Fraction HDR Brachytherapy is the first listed.
NCT07022470 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07022470 about?
NCT07022470 is a clinical study titled "Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).". This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
What is the current status of trial NCT07022470?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2025-06-03. Estimated completion is 2028-06.
What conditions does trial NCT07022470 study?
This clinical trial studies the following conditions: Cervical Cancers.
What interventions are being tested in trial NCT07022470?
The interventions under investigation include: 3-Fraction HDR Brachytherapy (RADIATION), 4-Fraction HDR Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT07022470?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07022470 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.